1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Baseline characteristics of 108 patients treated for VCFsa
Characteristic Perforation Group PVP Group P Value No. of patients 58 50 Mean age (yr) (range) 76.7 ± 4.2 77.5 ± 8.4 .35 No. of women (%) 48 42 Preop. VAS score 7.0 ± 2.1 7.0 ± 1.4 .82 Mean duration of symptoms (day) 127.8 ± 105 145.3 ± 112 .68 Posterior destruction of VB (+) 19 (+) 10 .09 (–) 39 (–) 40 No. of patients with preexisting VCFs (+) 34 (+) 31 .42 (–) 24 (–) 19 Distribution of treated VCFs T7-L5 T6-L4 Presence of kyphotic change (+) 15 (+) 18 .15 (–) 43 (–) 32 Preop. vertebral percentage of compression (%) 45.9 ± 29.7 42.5 ± 14.2 .64 Preop. intravertebral cleft on MRI (+) 30 (+) 15 .02 (–) 28 (–) 35 Communication of puncture holes (+) 15 (–) 43
-
Note:—preop indicates preoperative; VB, vertebral body.
-
↵a Statistical analyses were performed with the Mann-Whitney U test or the Fisher exact test.